TABLE 3.
≥50 y at inclusion (n = 106 437) | ≥75 y at inclusion (n = 21 852) | |||
---|---|---|---|---|
Trajectories of BZD dispensing (ref. non‐users) | Crude hazard ratios with 95% CI | Adjusted hazard ratios a with 95% CI | Crude hazard ratios with 95% CI | Adjusted hazard ratios a with 95% CI |
Occasional users | 0.91 0.83–0.99 | 0.99 0.99–1.00 | 1.00 0.99–1.00 | 1.00 0.99–1.00 |
Decreasing users | 0.92 0.85–0.99 | 0.90 0.74–1.08 | 0.88 0.67–1.15 | 0.92 0.68–1.28 |
Early increasing users | 3.35 2.96–3.79 | 1.86 1.62–2.14 | 2.08 1.73–2.50 | 1.87 1.53–2.27 |
Late increasing users | 3.04 2.63–3.52 | 1.36 1.15–1.60 | 1.92 1.58–2.33 | 1.81 1.47–2.23 |
survival model adjusted on: age at inclusion, sex, drugs dispensed during follow‐up and long‐term diseases (see Supplementary Table S2), somatic multimorbidity score (see Supplementary Table S3).
CI: confidence interval.